KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $13.6 billion.

  • Organon's Liabilities and Shareholders Equity rose 627.35% to $13.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 billion, marking a year-over-year increase of 911.68%. This contributed to the annual value of $13.1 billion for FY2024, which is 864.99% up from last year.
  • Latest data reveals that Organon reported Liabilities and Shareholders Equity of $13.6 billion as of Q3 2025, which was up 627.35% from $13.5 billion recorded in Q2 2025.
  • In the past 5 years, Organon's Liabilities and Shareholders Equity ranged from a high of $13.6 billion in Q3 2025 and a low of $9.6 billion during Q1 2021
  • In the last 5 years, Organon's Liabilities and Shareholders Equity had a median value of $11.0 billion in 2023 and averaged $11.6 billion.
  • As far as peak fluctuations go, Organon's Liabilities and Shareholders Equity plummeted by 792.24% in 2022, and later soared by 1580.09% in 2024.
  • Quarter analysis of 5 years shows Organon's Liabilities and Shareholders Equity stood at $10.7 billion in 2021, then rose by 2.57% to $11.0 billion in 2022, then increased by 10.07% to $12.1 billion in 2023, then rose by 8.65% to $13.1 billion in 2024, then grew by 3.44% to $13.6 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $13.6 billion for Q3 2025, versus $13.5 billion for Q2 2025 and $13.2 billion for Q1 2025.